The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022-Reference-Cited by-同舟云学术

The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022

Published:2022-10-02 Issue:1 Volume:13 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Sridhar Saranya^ORCID,Chicz Roman M.,Warren William,Tartaglia Jim,Savarino Stephen,Gurunathan Sanjay,Toussaint Jean-Francois

Funder

U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

Link

https://www.nature.com/articles/s41467-022-33549-6.pdf

Reference25 articles.

1. Memorandum of 30 Jun 2022—Fall 2022 COVID-19 Vaccine Strain Composition Selection Recommendation. https://www.fda.gov/media/159597/download (2022).

2. Anderson, E. M. et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell 184, 1858–1864 (2021).

3. Yamashita, T. et al. Preexisting humoral immunity cross-reacting with SARS-CoV-2 might prevent death due to COVID-19 in critical patients. J. Clin. Med. 11, 3870–3880 (2022).

4. Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489–1501.e15 (2020).

5. Sagar, M. et al. Recent endemic coronavirus infection is associated with less-severe COVID-19. J. Clin. Invest. 131, e143380 (2021).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A chimeric adenovirus‐vectored vaccine based on Beta spike and Delta RBD confers a broad‐spectrum neutralization against Omicron‐included SARS‐CoV‐2 variants;MedComm;2024-04-27

2. A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection;Nature Communications;2024-02-02

3. Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2;Scientific Reports;2024-01-23

4. Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study;Vaccines;2023-12-01

5. Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines;Cell Reports;2023-11